The week of 4-8 November 2024 is set aside to celebrate the work of nearly 1 million trustees volunteering for charities across the UK. Trustees are individuals responsible for the
Data Collection for metastatic breast cancer…
Kat wrote this blog for Metastatic May but we feel it should be shared again for Breast Cancer Awareness Month as data is a major problem and something that really
The Patience and Patients of Clinical Trials…
Clinical trials are one of those things that no one really cares about until you need to. In the UK we have a pretty impressive cancer trial landscape that’s recognised
In our recent Metastatic May campaign, the theme was ‘The Cost of Living’
In our recent Metastatic May campaign, the theme was ‘The Cost of Living’. Living with metastatic breast cancer affects personal finances, careers, and overall income. But we also explored the
Treatement lines and herceptin for HER2+ metastatic breast cancer
Any patient with metastatic breast cancer (MBC) will be familiar with the concept of ‘treatment lines’. Unlike primary breast cancer, where you undergo chemotherapy for a fixed time period, after
13th October – metastatic (secondary) breast cancer day – redefining MBC…
A friend a few weeks ago recently joined the statistic of 31 women that die every day of metastatic breast cancer, and we just hear the same words and comments.
Primary breast cancer tends to fill Breast Cancer Awareness Month…
Red Flags and DENOVO Breast Cancer Primary breast cancer tends to fill Breast Cancer Awareness Month. It’s a month where our social media, TV, radio, advertising and retail all turn
METUPUK Breast Cancer Awareness 2024 for metastatic breast cancer
METUPUK’ Breast Cancer Awareness Month campaign for October across the UK and on social media channels. Continuing the synergy with The Darker Side of Pink travelling campaign highlighting the 31 women a
I was diagnosed with ER/PR+ HER- primary breast cancer in February 2022….
I was diagnosed with ER/PR+ HER- primary breast cancer in February 2022. I was treated with a lumpectomy followed by 12 sessions of chemotherapy and 24 sessions of radiotherapy; I
Breast cancer patients denied life-extending drug by NICE
A cancer drug which received standing ovation from the Global Medical Community is being withheld from NHS breast cancer patients. METUPUK are devastated by NICE decision not to recommend the drug